Zurn Elkay Water Solutions Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Zurn Elkay Water Solutions Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.53B | Feb 6, 2024 |
| FY2023 | Dec 31, 2022 | $1.28B | Feb 6, 2024 |
| FY2023 | Dec 31, 2021 | $910.90M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $562.70M | Feb 14, 2023 |
| FY2020 | Mar 31, 2020 | $2.07B | May 12, 2020 |
| FY2021 | Dec 31, 2019 | $710.10M | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $2.05B | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $1.85B | May 12, 2020 |
| FY2019 | Mar 31, 2017 | $1.71B | May 14, 2019 |
| FY2018 | Mar 31, 2016 | $1.92B | May 14, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.53B | Feb 9, 2026 |
| FY2022 | Dec 31, 2022 | $340.30M | Feb 14, 2023 |
| FY2022 | Sep 30, 2022 | $417.70M | Feb 14, 2023 |
| FY2022 | Jun 30, 2022 | $284.20M | Feb 14, 2023 |
| FY2022 | Mar 31, 2022 | $239.60M | Feb 14, 2023 |
| FY2022 | Dec 31, 2021 | $232.30M | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $229.70M | Feb 14, 2023 |
| FY2022 | Jun 30, 2021 | $243.70M | Feb 14, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $575.20M | May 14, 2018 |
| FY2018 | Dec 31, 2017 | $492.30M | May 14, 2018 |
| FY2018 | Sep 30, 2017 | $510.80M | May 14, 2018 |
| FY2018 | Jun 30, 2017 | $487.70M | May 14, 2018 |
| FY2018 | Mar 31, 2017 | $503.60M | May 14, 2018 |
| FY2018 | Dec 31, 2016 | $451.80M | May 14, 2018 |
| FY2018 | Sep 30, 2016 | $491.00M | May 14, 2018 |
| FY2018 | Jun 30, 2016 | $471.80M | May 14, 2018 |
| FY2017 | Mar 31, 2016 | $492.60M | May 17, 2017 |
| FY2017 | Dec 31, 2015 | $460.20M | May 17, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $764.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $707.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $648.10M | Feb 9, 2026 |
| FY2022 | Dec 31, 2022 | $109.40M | Feb 14, 2023 |
| FY2022 | Sep 30, 2022 | $140.40M | Feb 14, 2023 |
| FY2022 | Jun 30, 2022 | $113.80M | Feb 14, 2023 |
| FY2022 | Mar 31, 2022 | $101.90M | Feb 14, 2023 |
| FY2022 | Dec 31, 2021 | $85.20M | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $95.80M | Feb 14, 2023 |
| FY2022 | Jun 30, 2021 | $103.80M | Feb 14, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $160.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $112.70M | Feb 9, 2026 |
| FY2022 | Dec 31, 2022 | $14.20M | Feb 14, 2023 |
| FY2022 | Sep 30, 2022 | ($19.10M) | Feb 14, 2023 |
| FY2022 | Jun 30, 2022 | $36.40M | Feb 14, 2023 |
| FY2022 | Mar 31, 2022 | $30.20M | Feb 14, 2023 |
| FY2022 | Dec 31, 2021 | ($66.40M) | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | $64.10M | Feb 14, 2023 |
| FY2022 | Jun 30, 2021 | $73.20M | Feb 14, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $278.90M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $244.60M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $191.40M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $107.10M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $107.00M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $81.00M | Feb 14, 2023 |
| FY2021 | Mar 31, 2020 | $104.10M | Feb 9, 2022 |
| FY2021 | Dec 31, 2019 | $77.40M | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $305.60M | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $266.40M | May 12, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Mar 31, 2020 | $16.20M | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $16.30M | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $13.30M | May 12, 2020 |
| FY2019 | Mar 31, 2017 | $10.40M | May 14, 2019 |
| FY2018 | Mar 31, 2016 | $12.40M | May 14, 2018 |
| FY2017 | Mar 31, 2015 | $12.80M | May 17, 2017 |
| FY2016 | Mar 31, 2014 | $13.00M | May 19, 2016 |
| FY2015 | Mar 31, 2013 | $13.70M | May 20, 2015 |
| FY2013 | Mar 31, 2012 | $15.40M | May 21, 2014 |
| FY2012 | Mar 31, 2011 | $11.50M | May 21, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $417.60M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $389.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $371.30M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $309.00M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $239.00M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $153.70M | Feb 14, 2023 |
| FY2021 | Mar 31, 2020 | $196.40M | Feb 9, 2022 |
| FY2021 | Dec 31, 2019 | $144.00M | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $433.10M | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $393.80M | May 12, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $346.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $293.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $253.90M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $97.00M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $223.60M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $196.30M | Feb 14, 2023 |
| FY2021 | Mar 31, 2020 | $298.60M | Feb 9, 2022 |
| FY2021 | Dec 31, 2019 | $174.70M | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $258.10M | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $228.50M | May 12, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Mar 31, 2020 | $41.40M | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $42.50M | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $38.00M | May 12, 2020 |
| FY2019 | Mar 31, 2017 | $50.80M | May 14, 2019 |
| FY2018 | Mar 31, 2016 | $52.10M | May 14, 2018 |
| FY2017 | Mar 31, 2015 | $48.80M | May 17, 2017 |
| FY2016 | Mar 31, 2014 | $52.20M | May 19, 2016 |
| FY2015 | Mar 31, 2013 | $60.10M | May 20, 2015 |
| FY2013 | Mar 31, 2012 | $58.50M | May 21, 2014 |
| FY2012 | Mar 31, 2011 | $37.60M | May 21, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.65B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.67B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $2.86B | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.08B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $3.40B | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | $3.63B | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $3.26B | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $3.42B | May 12, 2020 |
| FY2019 | Mar 31, 2017 | $3.54B | May 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.06B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.06B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $1.25B | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $951.30M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.96B | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | $2.31B | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $2.03B | May 12, 2020 |
| FY2019 | Mar 31, 2018 | $2.21B | May 14, 2019 |
| FY2018 | Mar 31, 2017 | $2.47B | May 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.60B | Feb 9, 2026 |
| FY2025 | Dec 31, 2022 | $1.62B | Feb 9, 2026 |
| FY2024 | Dec 31, 2021 | $126.40M | Feb 10, 2025 |
| FY2023 | Dec 31, 2020 | $1.44B | Feb 6, 2024 |
| FY2020 | Mar 31, 2020 | $1.31B | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $1.23B | May 12, 2020 |
| FY2019 | Mar 31, 2018 | $1.21B | May 14, 2019 |
| FY2018 | Mar 31, 2017 | $1.07B | May 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $795.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $794.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $796.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $777.00M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $254.10M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $244.80M | Feb 14, 2023 |
| FY2021 | Mar 31, 2020 | $200.50M | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $1.30B | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $1.28B | May 12, 2020 |
| FY2019 | Mar 31, 2017 | $1.22B | May 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.13B) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($1.17B) | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | ($1.18B) | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | ($1.16B) | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | ($1.24B) | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $116.00M | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | $85.90M | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $30.70M | May 12, 2020 |
| FY2019 | Mar 31, 2018 | $8.00M | May 14, 2019 |
| FY2018 | Mar 31, 2017 | ($55.50M) | May 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $300.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $198.00M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $136.70M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $124.80M | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $96.60M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $62.30M | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | $573.40M | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $292.50M | May 12, 2020 |
| FY2019 | Mar 31, 2018 | $193.20M | May 14, 2019 |
| FY2018 | Mar 31, 2017 | $490.10M | May 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $496.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $495.60M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $495.30M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $535.90M | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | $539.50M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.12B | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | $1.47B | May 12, 2020 |
| FY2020 | Mar 31, 2019 | $1.24B | May 12, 2020 |
| FY2019 | Mar 31, 2018 | $1.36B | May 14, 2019 |
| FY2018 | Mar 31, 2017 | $1.62B | May 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Feb 14, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Feb 14, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Feb 14, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Feb 14, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 166.98M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 170.31M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 172.26M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | 176.88M | Feb 6, 2024 |
| FY2022 | Dec 31, 2021 | 125.72M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | 119.55M | Feb 9, 2022 |
| FY2020 | Mar 31, 2020 | 119.72M | May 12, 2020 |
| FY2020 | Mar 31, 2019 | 104.84M | May 12, 2020 |
| FY2019 | Mar 31, 2018 | 104.18M | May 14, 2019 |
| FY2018 | Mar 31, 2017 | 103.60M | May 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.90M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $56.60M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $50.40M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $32.50M | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $36.40M | Feb 6, 2024 |
| FY2022 | Dec 31, 2020 | $28.80M | Feb 14, 2023 |
| FY2021 | Mar 31, 2020 | $9.80M | Feb 9, 2022 |
| FY2021 | Dec 31, 2019 | $0 | Feb 9, 2022 |
| FY2020 | Mar 31, 2019 | $0 | May 12, 2020 |
| FY2020 | Mar 31, 2018 | $0 | May 12, 2020 |